event tracking

Parkinson’s Disease

150 results.

August 9, 2022 Leveraging curiosity and diversity to elevate research: A Q&A with Dr. Alex Soto-Avellaneda

Exceptional science benefits from exceptional diversity, and Van Andel Institute is committed to increasing representation in the biomedical research community through a variety of training…

April 21, 2022 The future of Parkinson’s research and treatment: A Q&A with Dr. Anthony E. Lang (Part 2)

Each year during our Grand Challenges in Parkinson’s Disease symposium, Van Andel Institute presents the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research to…

April 20, 2022 Understanding the full spectrum of Parkinson’s disease: A Q&A with Dr. Anthony E. Lang (Part 1)

Each year during our Grand Challenges in Parkinson’s Disease symposium, Van Andel Institute presents the Jay Van Andel Award for Outstanding Achievement in Parkinson’s Disease Research to…

April 6, 2022 Top-line results reported from clinical trial of diabetes drug in Parkinson’s

This release has been republished from Cure Parkinson’s. Researchers from Cedars Sinai Hospital, Los Angeles, have presented their initial top line results of

April 1, 2022 Slowing or stopping Parkinson’s disease: Where are we?

If you read a lot about Parkinson’s disease, one term you’ll often see is “disease modification.” This bit of jargon has an important meaning —…

December 14, 2021 A year — and a quarter century — in review

As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…

November 15, 2021 Graduate student spotlight: Investigating the links between the immune system and Parkinson’s disease

Throughout the year, we highlight Van Andel Institute Graduate School’s doctoral students. This month, we’re featuring Alysa Kasen, a Ph.D. student in the lab of Dr.…